Acute Kidney Injury Prediction Model Using Cystatin-C, Beta-2 Microglobulin, and Neutrophil Gelatinase-Associated Lipocalin Biomarker in Sepsis Patients
Authors:
Open Access
- 1 March 2024
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nephrology and Renovascular Disease
- Vol. ume 17, 105-112
Abstract
Introduction: AKI is a frequent complication in sepsis patients and is estimated to occur in almost half of patients with severe sepsis. However, there is currently no effective therapy for AKI in sepsis. Therefore, the therapeutic approach is focused on prevention. Based on this, there is an opportunity to examine a panel of biomarker models for predicting AKI. Material and Methods: This prospective cohort study analysed the differences in Cystatin C, Beta-2 Microglobulin, and NGAL levels in sepsis patients with AKI and sepsis patients without AKI. The biomarker modelling of AKI prediction was done using machine learning, namely Orange Data Mining. In this study, 130 samples were analysed by machine learning. The parameters used to obtain the biomarker panel were 23 laboratory examination parameters. Results: This study used SVM and the Naïve Bayes model of machine learning. The SVM model’s sensitivity, specificity, NPV, and PPV were 50%, 94.4%, 71.4%, and 87.5%, respectively. For the Naïve Bayes model, the sensitivity, specificity, NPV, and PPV were 83.3%, 77.8%, 87.5%, and 71.4%, respectively. Discussion: This study’s SVM machine learning model has higher AUC and specificity but lower sensitivity. The Naïve Bayes model had better sensitivity; it can be used to predict AKI in sepsis patients. Conclusion: The Naïve Bayes machine learning model in this study is useful for predicting AKI in sepsis patients.Keywords
This publication has 21 references indexed in Scilit:
- Cystatin C and derived measures of renal function as risk factors for mortality and acute kidney injury in sepsis – A post-hoc analysis of the FINNAKI cohortJournal of Critical Care, 2022
- Developing an ensemble machine learning model for early prediction of sepsis-associated acute kidney injuryiScience, 2022
- Candidate Biomarkers for Sepsis-Associated Acute Kidney Injury Mechanistic StudiesShock, 2022
- The predict value of serum/urocystatin C on acute kidney injury in elderly patients with sepsisExperimental Gerontology, 2021
- Machine learning for early discrimination between transient and persistent acute kidney injury in critically ill patients with sepsisScientific Reports, 2021
- Sepsis-Associated Acute Kidney InjuryCritical Care Clinics, 2021
- THAI-ICU score as a simplified severity score for critically ill patients in a resource limited setting: Result from SEA-AKI study groupJournal of Critical Care, 2020
- Using the newer Kidney Disease: Improving Global Outcomes criteria, beta-2-microglobulin levels associate with severity of acute kidney injuryClinical Kidney Journal, 2018
- A review of micronutrients in sepsis: the role of thiamine,l-carnitine, vitamin C, selenium and vitamin DNutrition Research Reviews, 2018
- Biomarkers in Acute Kidney Injury2017